Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Expert Insights on Food and Drug Administration (FDA)

The Food and Drug Administration (FDA) is a U.S. government agency tasked with ensuring that no adulterated or misbranded foods, drugs, or medical devices enter interstate commerce. It also oversees dietary supplements, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics. It is also the agency that governs clinical trials of medications.

Gerson Lehrman Group Council Members are available to discuss Food and Drug Administration (FDA) via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Jim Farley, President, Cardinal Consulting and Training

Jim FarleyWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

PresidentCardinal Consulting and Training

Gregory Glover, Partner, Pharmaceutical Law Group PC

Gregory GloverWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

PartnerPharmaceutical Law Group PC

Bret Koplow, Partner, Head of Food & Drug Practice, SONNENSCHEIN, NATH & ROSENTHAL, LLP

Bret KoplowWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Partner, Head of Food & Drug PracticeSONNENSCHEIN, NATH & ROSENTHAL, LLP

Marc Scheineson, Partner & Chair, Food and Drug Practice, ALSTON & BIRD LLP

Marc ScheinesonWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Partner & Chair, Food and Drug PracticeALSTON & BIRD LLP

Barry Massie, Chief of the Cardiology Division , San Francisco Veterans Affairs Medical Center

Barry MassieWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Chief of the Cardiology Division San Francisco Veterans Affairs Medical Center

Browse all 274 Leading Experts

Recent Live Meetings

Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings

November 6, 2008 | Webcast

GLG Webcast: FDA Drug Reviews - Policies and Procedures - November 6, 2008 at 2:00 PM EDT

October 28, 2009 | Teleconference

Teleconference: Who Will Win the Anti-Obesity Pill Race? (9:00 AM EST / 13:00 GMT)

November 3, 2009 | Teleconference

Teleconference: Will Benlysta be the Miracle Drug for Lupus? (10:00 AM EST / 15:00 GMT)

Browse all 199 Live Meetings

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Cepheid Expects H1N1 FDA Approval

October 7, 2009

Ken Powell, President, Genesis Business Development, LLC

Roche Receives H1N1 FDA Emergency Use Authorization

November 16, 2009

Ken Powell, President, Genesis Business Development, LLC

FDA Publishes H1N1 Diagnostic Test Guidance

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

Quest Diagnostics Receives Second FDA H1N1 EUA

October 20, 2009

Ken Powell, President, Genesis Business Development, LLC

Fampridine Clears Major Hurdle at FDA Review Panel

October 14, 2009

Browse all 1135 GLG News Analyses

Contact Gerson Lehrman Group to engage a Food and Drug Administration (FDA) expert